Related Experiment Videos
Hepatocellular carcinoma in western Sydney
M J Hollands1, J F Huang, W Adams
1Department of Surgery, Westmead Hospital, N.S.W., Australia.
Annals of the Academy of Medicine, Singapore
|January 1, 1988
Summary
Hepatitis B infection is a key factor in hepatocellular carcinoma (HCC) development. While cirrhosis impacts survival, Hepatitis B does not, and AFP screening is limited in Caucasian populations.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Identifying predisposing factors and prognostic indicators is crucial for managing HCC.
- Hepatitis B infection is a known risk factor for HCC.
Purpose of the Study:
- To review cases of hepatocellular carcinoma at Westmead Hospital, Sydney.
- To identify predisposing conditions and factors influencing survival.
- To evaluate the utility of Alpha-fetoprotein (AFP) screening.
Main Methods:
- Retrospective review of 34 proven HCC cases (1980-1987).
- Analysis of patient history for Hepatitis B infection, sex steroid use, cirrhosis, and alcohol abuse.
- Multiple regression analysis to determine predictors of elevated AFP levels.
- Assessment of treatment modalities including resection and embolization.
Main Results:
- Hepatitis B infection was the major predisposing condition for HCC.
- Cirrhosis at diagnosis significantly influenced patient survival.
- Elevated AFP levels were observed in 15 of 34 patients; Hepatitis B infection was the sole independent determinant.
- AFP screening showed limited promise in the Caucasian population, except for those with Hepatitis B infection.
Conclusions:
- Hepatocellular carcinoma prognosis in Australia is poor, mirroring global trends.
- Increasing incidence is anticipated due to immigration from high-risk areas and rising Hepatitis B infection rates among drug addicts.
- Targeted screening strategies are needed, considering the limited utility of AFP in certain demographics.